what is compounded semaglutide and tirzepatide Semaglutide/Tirzepatide: Personalized, Affordable Medical Weight Loss TrimRX | Pen vs Vial

(2024, Clinical Diabetes) Study Design : Narrative review summarizing the ongoing Phase 3 clinical development program

Around 40% of patients stopped taking their GLP-1 drug within the first year, rising to nearly 60% by the end of two years

CoolSculpting may be a good solution for targeting and reducing stubborn fat bulges at any point in your weight loss journey

This isnt unique to GLP-1s

The concept of dose stepping, using a higher dose for initial weight loss and then transitioning to a lower dose for maintenance, could become the standard treatment paradigm if the data supports it

At 50 mg to 200 mg per dose, the high injection volume requires intramuscular (IM) administration or splitting the dose across multiple subcutaneous sites